beta-lactamase producing of detecting extended-spectrum beta-lactamase-producing

Background: Extended-spectrum beta-lactamases (ESBLs) have emerged as important mechanism of resistance among enterobacteriaceae family. These ESBL positive strains are major problem in hospitalized patients. The goal of this study was the survey emergence of multi-drug resistant ESBL producing strains among enterobacteriaceae members isolated from patients blood samples using BACTEC 9240 automatic system in south of Iran. Materials & Methods : In this cross-sectional study, 4825 blood samples were collected from hospitalized patients, and positive samples were detected by BACTEC automatic system. Positive blood cultures removed from BACTEC and subculture was performed on microbiological media including blood agar, chocolate agar and MacConkey agar. The isolates were identified based on biochemical tests embedded in the API-20E system. Susceptibility testing (disc diffusion) was performed according clinical and laboratory standards institute (CLSI, 2013) guidelines. Phenotypic detection of extended spectrum beta-lactamase producing isolates was performed by double disk synergy test (DDST). Results : Total 1145 (24%) blood cultures were positive that among them 248 (21.5%) belonged to the enterobacteriaceae family. The most common isolates in this family were Escherichia coli (46.5%), Klebsiella spp. (28%), Enterobacter spp. (13.5%). Among enterobacteriaceae family, ampicillin was most effective drug against Salmonella isolates. Escherichia coli was the most common ESBL-producing isolate (58% of isolates were ESBL positive). Respectively, polymyxin B, colistin, imipenem were the most effective drugs against ESBL-positive Klebsiella strains. The ESBL-positive Enterobacter strains showed lowest resistance to imipenem (7.7%). All ESBL positive Serratia isolates were sensitive to chloramphenicol, co-trimoxazole and imipenem. Conclusion: Results showed unfortunately betalactam antibiotics are not effective against more than 40% of bacteremia caused by Escherichia coli and Klebsiella and 39% bacteremia caused by Enterobacter . Multi drug resistance strains are increasing and treatment of infections causing by this isolates are major problem in Iran.

[1]  J. Mardaneh,et al.  Isolation and determination antimicrobial susceptibility pattern of Enterobacter cloacae strains isolated from consumed powdered infant formula milk in NICU ward , 2014 .

[2]  J. Mardaneh,et al.  PROFILE OF ANTIMICROBIAL SUSCEPTIBILITY ISOLATED MICROORGANISMS FROM HOSPITALIZED PATIENTS IN PICU WARD AND DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND ESBL-PRODUCING BACTERIA BY PHENOTYPIC METHODS , 2014 .

[3]  P. Gastmeier,et al.  Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization , 2014, Infection.

[4]  F. Naveca,et al.  Extended-spectrum beta-lactamase-producing bacteria isolated from hematologic patients in Manaus, State of Amazonas, Brazil , 2011, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[5]  D. Nair,et al.  Extended-spectrum β-lactamases in Gram Negative Bacteria , 2010, Journal of global infectious diseases.

[6]  A. Thakur,et al.  Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. , 2010, Journal of infection in developing countries.

[7]  S. Swedan,et al.  Extended Spectrum β-Lactamases among Gram-Negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan , 2009, International journal of microbiology.

[8]  P. Mathur,et al.  Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India. , 2009, Singapore medical journal.

[9]  W. Ko,et al.  Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  I. Mitov,et al.  Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital. , 2008, The Journal of hospital infection.

[11]  V. Rotimi,et al.  The Technical Aspects and Clinical Significance of Detecting Extended-Spectrum β-lactamase-Producing Enterobacteriaceae at a Tertiary-Care Hospital in Kuwait , 2008, Journal of chemotherapy.

[12]  J. Woo,et al.  Prevalence, microbiology, and clinical characteristics of extended-spectrum β-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea , 2007, European Journal of Clinical Microbiology and Infectious Diseases.

[13]  A. Kapil,et al.  Emerging resistance to carbapenems in a tertiary care hospital in north India. , 2006, The Indian journal of medical research.

[14]  K. Angamuthu,et al.  Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. , 2005, Saudi medical journal.

[15]  Y. Carmeli,et al.  Evaluation of an Accelerated Protocol for Detection of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli from Positive Blood Cultures , 2005, Journal of Clinical Microbiology.

[16]  Amita Jain,et al.  Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. , 2003, Journal of medical microbiology.

[17]  J. Quinn,et al.  Clinical Isolates of Enterobacteriaceae Producing Extended-Spectrum β-Lactamases: Prevalence of CTX-M-3 at a Hospital in China , 2003, Antimicrobial Agents and Chemotherapy.

[18]  G. Fadda,et al.  Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs , 2002, Antimicrobial Agents and Chemotherapy.

[19]  P. Bradford.  Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.

[20]  H. Goossens,et al.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.